Annovis Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
/ 
Frequently asked questions
To buy Annovis Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Annovis Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Annovis Bio Inc. is ANVS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Annovis Bio Inc. has its primary listing on New York Stock Exchange. You can trade Annovis Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Annovis Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Annovis Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Annovis Bio Inc..